Analysis

The future trajectory of BioNTech SE is becoming increasingly tied to a single, promising oncology asset. The company’s ambitious cancer...

While Palantir Technologies continues to post explosive growth figures in its home market, the data analytics firm is encountering mounting...

Microsoft finds itself navigating turbulent waters as two significant challenges converge. Investor sentiment has cooled, reflected in a declining share...

A significant shift in institutional holdings for streaming giant Netflix has emerged, coinciding with the company's ambitious push into live...

Strategy has set a historic corporate goal: to accumulate one million Bitcoin on its balance sheet. However, the path to...

The legal landscape for PayPal has grown increasingly complex, with the company now confronting a second major class-action lawsuit from...

Ocugen, Inc. has bolstered its balance sheet without initiating a new formal funding round. The capital infusion came via the...

Positive early-stage clinical data for its immunotherapy drug Anktiva, presented by the company's founder, provided a pre-market lift to ImmunityBio...

A pivotal installation at a leading European research center underscores the accelerating commercial trajectory for ASML Holding NV's most advanced...

A significant legal chapter has concluded for former shareholders of animal health company Covetrus. The path is now clear for...